184 related articles for article (PubMed ID: 16489585)
41. Prion protein structure is affected by pH-dependent interaction with membranes: a study in a model system.
Re F; Sesana S; Barbiroli A; Bonomi F; Cazzaniga E; Lonati E; Bulbarelli A; Masserini M
FEBS Lett; 2008 Jan; 582(2):215-20. PubMed ID: 18082145
[TBL] [Abstract][Full Text] [Related]
42. Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations.
Jackson GS; Hosszu LL; Power A; Hill AF; Kenney J; Saibil H; Craven CJ; Waltho JP; Clarke AR; Collinge J
Science; 1999 Mar; 283(5409):1935-7. PubMed ID: 10082469
[TBL] [Abstract][Full Text] [Related]
43. Differential solubility of prions is associated in manifold phenotypes.
Kuczius T; Karch H; Groschup MH
Mol Cell Neurosci; 2009 Nov; 42(3):226-33. PubMed ID: 19607920
[TBL] [Abstract][Full Text] [Related]
44. The toxicity of prion protein fragment PrP(106-126) is not mediated by membrane permeabilization as shown by a M112W substitution.
Henriques ST; Pattenden LK; Aguilar MI; Castanho MA
Biochemistry; 2009 May; 48(19):4198-208. PubMed ID: 19301918
[TBL] [Abstract][Full Text] [Related]
45. CD and NMR studies of prion protein (PrP) helix 1. Novel implications for its role in the PrPC-->PrPSc conversion process.
Ziegler J; Sticht H; Marx UC; Müller W; Rösch P; Schwarzinger S
J Biol Chem; 2003 Dec; 278(50):50175-81. PubMed ID: 12952977
[TBL] [Abstract][Full Text] [Related]
46. Effects of trimethylamine N-oxide (TMAO) and crowding agents on the stability of RNA hairpins.
Pincus DL; Hyeon C; Thirumalai D
J Am Chem Soc; 2008 Jun; 130(23):7364-72. PubMed ID: 18479134
[TBL] [Abstract][Full Text] [Related]
47. Core structure of amyloid fibrils formed by residues 106-126 of the human prion protein.
Walsh P; Simonetti K; Sharpe S
Structure; 2009 Mar; 17(3):417-26. PubMed ID: 19278656
[TBL] [Abstract][Full Text] [Related]
48. Clustered negative charges on the lipid membrane surface induce beta-sheet formation of prion protein fragment 106-126.
Miura T; Yoda M; Takaku N; Hirose T; Takeuchi H
Biochemistry; 2007 Oct; 46(41):11589-97. PubMed ID: 17887730
[TBL] [Abstract][Full Text] [Related]
49. Enhanced prion protein stability coupled to DNA recognition and milieu acidification.
Marques AF; Cordeiro Y; Silva JL; Lima LM
Biophys Chem; 2009 May; 141(2-3):135-9. PubMed ID: 19286300
[TBL] [Abstract][Full Text] [Related]
50. PrP N-terminal domain triggers PrP(Sc)-like aggregation of Dpl.
Erlich P; Cesbron JY; Lemaire-Vieille C; Curt A; Andrieu JP; Schoehn G; Jamin M; Gagnon J
Biochem Biophys Res Commun; 2008 Jan; 365(3):478-83. PubMed ID: 17997980
[TBL] [Abstract][Full Text] [Related]
51. Analysis of PrP conformation using circular dichroism.
Han S; Hill AF
Methods Mol Biol; 2008; 459():145-59. PubMed ID: 18576154
[TBL] [Abstract][Full Text] [Related]
52. Unraveling the details of prion (con)formation(s): recent advances by mass spectrometry.
Principe S; Maras B; Schininà ME; Pocchiari M; Cardone F
Curr Opin Drug Discov Devel; 2008 Sep; 11(5):697-707. PubMed ID: 18729021
[TBL] [Abstract][Full Text] [Related]
53. Counteracting osmolyte trimethylamine N-oxide destabilizes proteins at pH below its pKa. Measurements of thermodynamic parameters of proteins in the presence and absence of trimethylamine N-oxide.
Singh R; Haque I; Ahmad F
J Biol Chem; 2005 Mar; 280(12):11035-42. PubMed ID: 15653673
[TBL] [Abstract][Full Text] [Related]
54. Atypical effect of salts on the thermodynamic stability of human prion protein.
Apetri AC; Surewicz WK
J Biol Chem; 2003 Jun; 278(25):22187-92. PubMed ID: 12676939
[TBL] [Abstract][Full Text] [Related]
55. Lipid interaction converts prion protein to a PrPSc-like proteinase K-resistant conformation under physiological conditions.
Wang F; Yang F; Hu Y; Wang X; Wang X; Jin C; Ma J
Biochemistry; 2007 Jun; 46(23):7045-53. PubMed ID: 17503780
[TBL] [Abstract][Full Text] [Related]
56. Photo-induced crosslinking of prion protein oligomers and prions.
Piening N; Weber P; Högen T; Beekes M; Kretzschmar H; Giese A
Amyloid; 2006 Jun; 13(2):67-77. PubMed ID: 16911960
[TBL] [Abstract][Full Text] [Related]
57. Conformational changes and development of proteinase K resistance in surface-immobilized PrP.
Leclerc E; Vetter S
Arch Virol; 2008; 153(4):683-91. PubMed ID: 18278426
[TBL] [Abstract][Full Text] [Related]
58. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues.
Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM
J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541
[TBL] [Abstract][Full Text] [Related]
59. Hydrogen/deuterium exchange mass spectrometry identifies two highly protected regions in recombinant full-length prion protein amyloid fibrils.
Nazabal A; Hornemann S; Aguzzi A; Zenobi R
J Mass Spectrom; 2009 Jun; 44(6):965-77. PubMed ID: 19283723
[TBL] [Abstract][Full Text] [Related]
60. Ovine plasma prion protein levels show genotypic variation detected by C-terminal epitopes not exposed in cell-surface PrPC.
Thackray AM; Fitzmaurice TJ; Hopkins L; Bujdoso R
Biochem J; 2006 Dec; 400(2):349-58. PubMed ID: 16881870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
